- Home
- PRSO vs CURX Comparison
PRSO vs CURX Comparison
Compare PRSO & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRSO | CURX |
|---|---|---|
| Founded | 2008 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8M | 7.6M |
| IPO Year | 2001 | 2025 |
Fundamental Metrics
Financial Performance| Metric | PRSO | CURX |
|---|---|---|
| Price | $0.89 | $0.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 488.1K | ★ 2.7M |
| Earning Date | 03-18-2026 | 09-09-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,001,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $35.76 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $0.52 | $3.61 |
| 52 Week High | $2.37 | $8.60 |
Technical Indicators
Market Signals| Indicator | PRSO | CURX |
|---|---|---|
| Relative Strength Index (RSI) | 45.01 | 32.40 |
| Support Level | $0.83 | $0.27 |
| Resistance Level | $0.89 | $0.31 |
| Average True Range (ATR) | 0.06 | 0.03 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 47.78 | 11.45 |
Price Performance
Historical ComparisonAbout PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
About CURX Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.